Skip to content

Bacampicillin

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: bacampicillin HCl, bacampicillin hydrochloride, carampicillin

OfmFDA approvedATC J01CA06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Bacampicillin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1980. DrugCentral lists 1 molecular target, including mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB. Recorded indications include Gonorrhea, Haemophilus influenzae pneumonia, Infection of skin AND/OR subcutaneous tissue and Infective otitis media.

  • Approval status: ofm (first approved 1980 by the FDA).
  • Molecular targets: mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (1 listed in DrugCentral).
  • Indications: Gonorrhea, Haemophilus influenzae pneumonia, Infection of skin AND/OR subcutaneous tissue, Infective otitis media and Pharyngitis and others.
  • ATC code: J01CA06 (Penicillins with extended spectrum).
  • Molecular formula: C21H27N3O7S; molecular weight 465.52 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (7)

  • Gonorrhea
  • Haemophilus influenzae pneumonia
  • Infection of skin AND/OR subcutaneous tissue
  • Infective otitis media
  • Pharyngitis
  • Sinusitis
  • Urinary tract infectious disease

Off-label uses (1)

  • Cholangitis

Contraindications (3)

  • Infectious mononucleosis
  • Kidney disease
  • Pseudomembranous enterocolitis

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Bacterial penicillin-binding proteinmrcA|mrcB|dacC|mrdA|ftsI|dacA|dacBinhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1980-12-22FDA——

ATC classification

ATC codeTherapeutic hierarchy
J01CA06ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › BETA-LACTAM ANTIBACTERIALS, PENICILLINS › Penicillins with extended spectrum

Chemical structure

Molecular formulaC21H27N3O7S
Molecular weight465.52 g/mol
CAS number50972-17-3
InChIKeyPFOLLRNADZZWEX-FFGRCDKISA-N
PubChem CID441397
CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)C1=CC=CC=C1)C2=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Bacampicillin used for?

DrugCentral lists the following indications for Bacampicillin: Gonorrhea, Haemophilus influenzae pneumonia, Infection of skin AND/OR subcutaneous tissue, Infective otitis media, Pharyngitis, Sinusitis and Urinary tract infectious disease.

How does Bacampicillin work?

Its molecular targets in DrugCentral include mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB (inhibitor).

When was Bacampicillin first approved?

Bacampicillin was first approved by the FDA in 1980.

What is the chemical formula of Bacampicillin?

Bacampicillin has the molecular formula C21H27N3O7S and a molecular weight of 465.52 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1980-12-22
AgencyFDA
Targets1
Indications7
FormulaC21H27N3O7S
DrugCentral ID280
Interactive profile